Avita Medical News

Avita Medical Price Target Cut 9% to A$2.75/Share by Wilsons

Avita Medical Price Target Cut 9% to A$2.75/Share by Wilsons

Dow JonesMay 14 18:28 ET

AVITA Downgraded by Piper Sandler Over Sales Outlook

Seeking AlphaMay 14 14:04 ET

Bank of America Securities Remains a Buy on Avita Medical (RCEL)

TipRanksMay 14 08:56 ET

Avita Medical Is Maintained at Overweight by Cantor Fitzgerald

Avita Medical Is Maintained at Overweight by Cantor Fitzgerald

Dow JonesMay 14 08:53 ET

Avita Medical Price Target Cut to $21.00/Share From $22.00 by Cantor Fitzgerald

Avita Medical Price Target Cut to $21.00/Share From $22.00 by Cantor Fitzgerald

Dow JonesMay 14 08:53 ET

Express News | Cantor Fitzgerald Maintains Overweight on AVITA Medical, Lowers Price Target to $21

BenzingaMay 14 08:43 ET

AVITA Medical Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/14/2024 161.52% Cantor Fitzgerald $22 → $21 Maintains Overweight 04/11/2024 — BTIG Downgrades Buy → Ne

BenzingaMay 14 08:42 ET

Q1 2024 AVITA Medical Inc Earnings Call

Yahoo FinanceMay 14 08:12 ET

Piper Sandler Reaffirms Their Hold Rating on Avita Medical (RCEL)

TipRanksMay 14 07:21 ET

Piper Sandler Downgrades Avita Medical to Neutral From Overweight, Price Target Is $9

Piper Sandler Downgrades Avita Medical to Neutral From Overweight, Price Target is $9.

MT NewswiresMay 14 07:18 ET

Steady Performance and Promising Outlook: A Buy Rating for Avita Medical

TipRanksMay 14 07:15 ET

AVITA Medical, Inc. (RCEL) Q1 2024 Earnings Call Transcript

AVITA Medical, Inc. (RCEL) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 14 06:38 ET

AVITA Medical Inc (AVHHL) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges ...

Yahoo FinanceMay 14 03:04 ET

Avita Medical Widens Q1 Loss as Sales, Marketing Expense Jumps; Shares Up 10%

Avita Medical (ASX:AVH) widened first-quarter net loss to $18.7 million, or $0.73 per share, from $9.2 million, or $0.37 per share, in the fourth quarter of 2023. Revenue rose on-quarter to $11.1 mill

MT NewswiresMay 13 22:10 ET

10-Q: Quarterly report

SEC announcementMay 13 16:09 ET · Announcements

Express News | AVITA Medical Inc: Expect to Achieve Previously Given Guidance of Cashflow Break Even and Gaap Profitability No Later Than Q3 of 2025

ReutersMay 13 16:03 ET

Express News | AVITA Medical Inc: Commercial Revenue for FY Expected to Be in Lower End of Our Previously Provided Guidance Range of $78.5 to $84.5 Mln

ReutersMay 13 16:03 ET

1Q Rev $11.1M >AVH.AX.AU

1Q Rev $11.1M >AVH.AX.AU

Dow JonesMay 13 16:03 ET

1Q Loss/Shr 73c >AVH.AX.AU

1Q Loss/Shr 73c >AVH.AX.AU

Dow JonesMay 13 16:03 ET

Express News | AVITA Medical Inc: Commercial Revenue for Q2 2024 Is Expected to Be in Range of $14.3 to $15.3 Mln

ReutersMay 13 16:02 ET